CompletedNCT03866252
LSD-Assisted Therapy for Major Depression
About this title
Read the official source — NCT03866252Medication studyAges 25+Switzerland
Understand this study
Who was this study for?
Listed age limits: from 25 years.
- Listed locations
- BaselSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: November 1, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 60
- Sponsor
- University Hospital, Basel, Switzerland
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Switzerland
- Age range
- Over 25 Years
- Official registry ID
- NCT03866252
- Official title
Show the full official title
LSD Therapy for Persons Suffering From Major Depression: A Randomised, Double-blind, Active-placebo Controlled Phase II Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Basel
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University Hospital, Basel, Switzerland, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including LSD.
Who was this study for?
Listed age limits: from 25 years.
